Question Title

* 1. Your details

Question Title

* 2. Please tick the activities completed from the available in the June edition and complete the relevant reflections below. We will process and send through a certificated for you total time for self updated into your CPD home.

Question Title

* 3. To finalise your CPD, please complete the 5 reflective questions for each article read.

Feature - Hepatocellular Carcinoma and Chronic Hepatitis B: The GP’s Role

How does the information presented in this session compare with my current clinical approach to Hepatitis B?

Question Title

* 4. Feature Hepatocellular Carcinoma and Chronic Hepatitis B: The GP’s Role

What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 5. Feature - Hepatocellular Carcinoma and Chronic Hepatitis B: The GP’s Role

What specific changes can I implement in my clinical practice to improve management of Chronic Hepatitis B?

Question Title

* 6. Feature - Hepatocellular Carcinoma and Chronic Hepatitis B: The GP’s Role

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 7. Feature - Hepatocellular Carcinoma and Chronic Hepatitis B: The GP’s Role

How will I monitor the impact of these changes in practice over time?

Question Title

* 8. Feature - Hepatocellular Carcinoma and Chronic Hepatitis B: The GP’s Role

Learning outcome - Discuss HCC risk and surveillance with patients with a diagnosis of Hep B.

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 9. Feature - New RACGP advice on breast cancer

How does the information presented in this session compare with my current clinical approach to conversations with female patients regarding their breast cancer risk?

Question Title

* 10. Feature - New RACGP advice on breast cancer

What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 11. Feature - New RACGP advice on breast cancer

What specific changes can I implement in my clinical practice to improve management of patients at risk of breast cancer?

Question Title

* 12. Feature - New RACGP advice on breast cancer

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 13. Feature - New RACGP advice on breast cancer

How will I monitor the impact of these changes in practice over time?

Question Title

* 14. Feature - New RACGP advice on breast cancer

Learning outcome - Apply current evidence-based strategies for breast cancer prevention and early detection, including the use of personalised risk assessments, breast density awareness, and shared decision-making approaches, to support informed screening and management choices in general practice.

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 15. Clinical Update - Ten-minute consult – iron deficiency in children

How does the information presented in this session compare with my current clinical approach to children with iron deficiency?

Question Title

* 16. Clinical Update - Ten-minute consult – iron deficiency in children
What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 17. Clinical update - Ten-minute consult – iron deficiency in children
What specific changes can I implement in my clinical practice to improve management of iron deficiency in children?

Question Title

* 18. Clinical update - Ten-minute consult – iron deficiency in children

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 19. Clinical Update - Ten-minute consult – iron deficiency in children

How will I monitor the impact of these changes in practice over time?

Question Title

* 20. Clinical Update - Ten-minute consult – iron deficiency in children

Learning outcome - Identify and apply current evidence-based clinical criteria to diagnose iron deficiency and iron deficiency anaemia in children, including appropriate use of laboratory investigations and consideration of age-specific reference ranges and risk factors.

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 21. Clinical Update - Advances in laser surgery

How does the information presented in this session compare with my current clinical approach to conversations with patients who are considering laser eye surgery?

Question Title

* 22. Clinical Update -Advances in laser surgery
What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 23. Clinical update - Advances in laser surgery
What specific changes can I implement in my clinical practice to improve management of patients with eye conditions suitable for laser eye surgery?

Question Title

* 24. Clinical Update - Advances in laser surgery

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 25. Clinical update - Advances in laser surgery

How will I monitor the impact of these changes in practice over time?

Question Title

* 26. Clinical Update -Advances in laser surgery

Learning outcome - Describe recent advances in laser eye surgery for cataract surgery and correction of reading problems

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 27. Clinical Update -Immunotherapy related cutaneous toxicity

How does the information presented in this session compare with my current clinical approach to patients who have immunotherapy related cutaneous toxicity?

Question Title

* 28. Clinical Update -Immunotherapy related cutaneous toxicity

What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 29. Clinical update -Immunotherapy related cutaneous toxicity

What specific changes can I implement in my clinical practice to improve my to patients undergoing immunotherapy with potential cutaneous toxicity?

Question Title

* 30. Clinical Update - Immunotherapy related cutaneous toxicity

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 31. Clinical update -Immunotherapy related cutaneous toxicity

How will I monitor the impact of these changes in practice over time?

Question Title

* 32. Clinical Update -Immunotherapy related cutaneous toxicity

Learning outcome - Identify cutaneous eruptions related to immunotherapy and facilitate rapid access to appropriate dermatology services.

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 33. Clinical Update - Focal therapy for prostate cancer: Precision with fewer side effects

How does the information presented in this session compare with my current approach to patients with prostate cancer?

Question Title

* 34. Clinical Update -Focal therapy for prostate cancer: Precision with fewer side effects

What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 35. Clinical Update -Focal therapy for prostate cancer: Precision with fewer side effects

What specific changes can I implement in my clinical practice to ensure prompt diagnosis of prostate cancer ?

Question Title

* 36. Clinical Update - Focal therapy for prostate cancer: Precision with fewer side effects

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 37. Clinical update - Focal therapy for prostate cancer: Precision with fewer side effects

How will I monitor the impact of these changes in practice over time?

Question Title

* 38. Clinical Update -Focal therapy for prostate cancer: Precision with fewer side effects

Learning outcome - Evaluate the emerging role of focal therapy in the management of intermediate-risk prostate cancer, including patient selection and clinical benefit.

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 39. Clinical Update - Exercise in cancer care: It is time to deliver

How does the information presented in this session compare with my current clinical approach to conversations about the benefits of exercise with patients undergoing cancer treatment?

Question Title

* 40. Clinical Update - Exercise in cancer care: It is time to deliver

What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 41. Clinical Update - Exercise in cancer care: It is time to deliver

What specific changes can I implement in my clinical practice to identify patients who are undergoing cancer treatment who wish to exercise ?

Question Title

* 42. Clinical Update - Exercise in cancer care: It is time to deliver

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 43. Clinical update - Exercise in cancer care: It is time to deliver

How will I monitor the impact of these changes in practice over time?

Question Title

* 44. Clinical Update - Exercise in cancer care: It is time to deliver

Learning outcome - Integrate evidence-based exercise recommendations into cancer care by initiating conversations with patients and facilitating appropriate referrals to accredited exercise professionals.

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 45. Clinical Update - Can aspirin prevent hepatocellular carcinoma in people with cirrhosis?

How does the information presented in this session compare with my current clinical approach to conversations with patients with cirrhosis?

Question Title

* 46. Clinical Update - Can aspirin prevent hepatocellular carcinoma in people with cirrhosis?

What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 47. Clinical Update - Can aspirin prevent hepatocellular carcinoma in people with cirrhosis?

What specific changes can I implement in my clinical practice when consulting with patients who have cirrhosis ?

Question Title

* 48. Clinical Update - Can aspirin prevent hepatocellular carcinoma in people with cirrhosis?

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 49. Clinical update - Can aspirin prevent hepatocellular carcinoma in people with cirrhosis?

How will I monitor the impact of these changes in practice over time?

Question Title

* 50. Clinical Update - Can aspirin prevent hepatocellular carcinoma in people with cirrhosis?

Learning outcome - Assess the potential role of aspirin in the primary prevention of hepatocellular carcinoma in patients with cirrhosis, including the rationale for its use, current evidence, and implications for future clinical practice.

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 51. Guest Column - How to support patients after a cancer diagnosis

How does the information presented in this session compare with my current clinical approach to supporting patients with a recent cancer diagnosis?

Question Title

* 52. Guest Column - How to support patients after a cancer diagnosis

What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 53. Guest Column - How to support patients after a cancer diagnosis

What specific changes can I implement in my clinical practice to improve management of patients with a recent cancer diagnosis?

Question Title

* 54. Guest Column - How to support patients after a cancer diagnosis

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 55. Guest Column - How to support patients after a cancer diagnosis

How will I monitor the impact of these changes in practice over time?

Question Title

* 56. Guest Column - How to support patients after a cancer diagnosis

Learning outcome - Implement supportive care strategies for patients newly diagnosed with cancer by providing evidence-based resources, initiating timely referrals, and addressing their emotional and psychosocial needs

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 57. Guest Column - Addressing healthcare gaps for tic disorders

How does the information presented in this session compare with my current clinical approach to conversations with my patients and families of those with potential tic disorders?

Question Title

* 58. Guest Column - Addressing healthcare gaps for tic disorders

What gaps or areas for improvement have I identified in my knowledge, skills or approach?

Question Title

* 59. Guest Column - Addressing healthcare gaps for tic disorders

What specific changes can I implement in my clinical practice?

Question Title

* 60. Guest Column - Addressing healthcare gaps for tic disorders

What barriers might I face in applying these changes, and how can I address them?

Question Title

* 61. Guest Column - Addressing healthcare gaps for tic disorders

How will I monitor the impact of these changes in practice over time?

Question Title

* 62. Guest Column -Addressing healthcare gaps for tic disorders

Learning outcome - Recognise and differentiate tic disorders in children to facilitate timely diagnosis, appropriate management, and referral when needed, ensuring families receive accurate information and support

  Meets Partially Did not meet
How did this article meet the learning objective?

Question Title

* 63. Podcast - Aortic stenosis

Learning outcome - Recognise the clinical features, diagnostic approach, and current management options for aortic stenosis, and apply this knowledge to optimise timely referral, shared decision-making, and coordinated care for patients in general practice.

  Meets Partially Did not meet
How did this podcast meet the learning objective?

Question Title

* 64. Podcast - advancing radiation oncology

Learning outcome - Describe the role and relevance of clinical trials in radiation oncology, and apply this understanding to support informed discussions with patients about trial participation, emerging treatment options, and referral pathways in general practice.

  Meets Partially Did not meet
How did this podcast meet the learning objective?

T